Skip to Content
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 22, Issue 6

2015 December - 22 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (22)

  • Article
  • Open Access
45 Citations
1,893 Views
11 Pages

Enablers and Barriers in Delivery of a Cancer Exercise Program: The Canadian Experience

  • D. Santa Mina,
  • A. Petrella,
  • K.L. Currie,
  • K. Bietola,
  • S.M.H. Alibhai,
  • J. Trachtenberg,
  • P. Ritvo and
  • A.G. Matthew

1 December 2015

Background: Exercise is an important therapy to improve well-being after a cancer diagnosis. Accordingly, cancer-exercise programs have been developed to enhance clinical care; however, few programs exist in Canada. Expansion of cancer-exercise progr...

  • Article
  • Open Access
11 Citations
978 Views
7 Pages

Pilot of Three Objective Markers of Physical Health and Chemotherapy Toxicity in Older Adults

  • T. Hsu,
  • R. Chen,
  • S.C.X. Lin,
  • S. Djalalov,
  • A. Horgan,
  • L.W. Le and
  • N. Leighl

1 December 2015

Backgroun: Patient function is a key part of the clinical decision to offer chemotherapy and has, in earlier studies, been associated with chemotherapy toxicity. Objective testing might be more accurate than patient-reported or physician-assessed phy...

  • Article
  • Open Access
7 Citations
843 Views
7 Pages

1 December 2015

Purpose: We examined access to locally developed and other available clinical practice guidelines (cpgs) for the management of cancer and evaluated how to improve uptake. Methods: A 12-question online survey was administered to 772 members of 12 mult...

  • Article
  • Open Access
10 Citations
948 Views
6 Pages

1 December 2015

Introduction: Stage iii lung cancer is the most advanced stage of lung cancer for which the potential of curative treatment is often discussed. However, a large proportion of patients are treated with palliative intent. An understanding of the time-d...

  • Article
  • Open Access
3 Citations
940 Views
7 Pages

1 December 2015

Background: In patients with advanced-stage endometrial carcinoma (eca), extended-field radiotherapy (efrt) is traditionally delivered by the 3-dimensional conformal (3d-crt) 4-field box technique. In recent years, the use of intensity-modulated radi...

  • Article
  • Open Access
26 Citations
1,328 Views
5 Pages

1 December 2015

Background: Treatment of malignant pericardial effusion remains controversial, because no randomized controlled trials have been conducted to determine the best approach, and results of retrospective studies have been inconsistent. The objective of t...

  • Article
  • Open Access
23 Citations
2,097 Views
10 Pages

1 December 2015

Historically, cancer has occurred at a lower rate in aboriginal populations; however, it is now dramatically increasing. Unless preventive measures are taken, cancer rates among aboriginal peoples are expected to soon surpass those in non-aboriginal...

  • Short Communication
  • Open Access
6 Citations
751 Views
3 Pages

Treatment Patterns among Canadian Men Diagnosed with Localized Low-Risk Prostate Cancer

  • C. Sandoval,
  • K. Tran,
  • R. Rahal,
  • G. Porter,
  • S. Fung,
  • C. Louzado,
  • J. Liu,
  • H. Bryant and
  • in collaboration with the System Performance Steering Committee and Technical Working Group

1 December 2015

In general, guideline-recommended treatment options for men with low-risk prostate cancer (pca) include active surveillance, radical prostatectomy, and external-beam radiation therapy or brachytherapy. Because of the concern about overdiagnosis and c...

  • Case Report
  • Open Access
14 Citations
1,012 Views
3 Pages

1 December 2015

Reactivation of hepatitis B virus (hbv) is a reported complication for patients undergoing chemotherapy, particularly immunochemotherapy with anti-CD20 agents such as rituximab. However, as the use of molecularly targeted agents increases, the risk o...

  • Article
  • Open Access
27 Citations
1,614 Views
16 Pages

Wellness beyond Cancer Program: Building an Effective Survivorship Program

  • M. Rushton,
  • R. Morash,
  • G. Larocque,
  • C. Liska,
  • L. Stoica,
  • C. DeGrasse and
  • R. Segal

1 December 2015

Background: The Wellness Beyond Cancer Program (wbcp) was launched in 2012, first accepting patients with colorectal cancer (crc) and, subsequently, those with breast cancer (bca), with the aim of standardizing and streamlining the discharge process...

  • Article
  • Open Access
7 Citations
972 Views
8 Pages

Management and Outcomes of Localized Esophageal and Gastroesophageal Junction Cancer in Older Patients

  • X. Qu,
  • J. Biagi,
  • A. Banashkevich,
  • C.D. Mercer,
  • L. Tremblay and
  • A. Mahmud

1 December 2015

Background: Older patients are commonly excluded from clinical trials in esophageal and gastroesophageal junction (gej) cancer. High-level evidence to guide management in this group is lacking. In the present study, we compared outcomes and described...

  • Article
  • Open Access
25 Citations
1,182 Views
10 Pages

1 December 2015

Background: Previous Canadian cost-effectiveness analyses in cancer based on the EQ-5D-3L (EuroQoL, Rotterdam, Netherlands) have commonly used U.K. or U.S. tariffs because the Canadian equivalent only just recently became available. The implications...

  • Article
  • Open Access
7 Citations
1,116 Views
4 Pages

1 December 2015

Background: During radiotherapy for breast cancer, patients are greatly affected by pain, infection, and delayed healing of wounds caused by radiodermatitis. In the present study, we aimed to determine the efficacy of Liu-He-Dan in treating radioderm...

  • Article
  • Open Access
1 Citations
704 Views
5 Pages

Analysis of Liver-Directed Therapies in U.S. Cancer Patients

  • O.B. Alese,
  • S. Kim,
  • Z. Chen,
  • S.S. Ramalingam,
  • T.K. Owonikoko and
  • B.F. El-Rayes

1 December 2015

Background: The liver is a common site of primary and metastatic cancer. Liver-directed therapies are commonly used to treat cancer involving the liver. We report on the patterns, predictors, and outcomes of liver-directed therapies in hospitalized c...

  • Article
  • Open Access
4 Citations
874 Views
8 Pages

Risk Perception and Psychological Morbidity in Men at Elevated Risk for Prostate Cancer

  • A.G. Matthew,
  • T. Davidson,
  • S. Ochs,
  • K.L. Currie,
  • A. Petrella and
  • A. Finelli

1 December 2015

Objective: As prostate-specific antigen (psa) makes prostate cancer (pca) screening more accessible, more men are being identified with conditions that indicate high risk for developing pca, such as elevated psa and high-grade intraepithelial neoplas...

  • Article
  • Open Access
13 Citations
969 Views
8 Pages

Quantifying Treatment Delays in Adolescents and Young Adults with Cancer at McGill University

  • Y. Xu,
  • M. Stavrides-Eid,
  • A. Baig,
  • M. Cardoso,
  • Y.S. Rho,
  • W.M. Shams,
  • A. Mamo and
  • P. Kavan

1 December 2015

Background: Since the end of the 1980s, the magnitude of survival prolongation or mortality reduction has not been the same for adolescents and young adults (ayas) with cancer as for their older and younger counterparts. Precise reasons for those obs...

  • Article
  • Open Access
23 Citations
1,166 Views
7 Pages

A Population-Based Study of the Epidemiology of Pancreatic Cancer: A Brief Report

  • R.S. Raju,
  • N. Coburn,
  • N. Liu,
  • J.M. Porter,
  • S.J. Seung,
  • M.C. Cheung,
  • N. Goyert,
  • N.B. Leighl,
  • J.S. Hoch and
  • N. Mittmann
  • + 4 authors

1 December 2015

Objective: Administrative data are used to describe the pancreatic cancer (pcc) population. The analysis examines demographic details, incidence, site, survival, and factors influencing mortality in a cohort of individuals diagnosed with pcc. Methods...

  • Article
  • Open Access
11 Citations
1,499 Views
8 Pages

Characteristics Affecting Survival after Locally Advanced Colorectal Cancer in Quebec

  • L. Perron,
  • J.M. Daigle,
  • N. Vandal,
  • M.H. Guertin and
  • J. Brisson

1 December 2015

Background: We estimated the relations of sociodemographic, organizational, disease, and treatment variables with the risk of death from colorectal cancer (CRC) in a Quebec population-based sample of patients with locally advanced CRC (LACRC) who und...

  • Case Report
  • Open Access
12 Citations
890 Views
5 Pages

1 December 2015

Fewer than 2% of patients with metastatic prostate cancer (pca) develop brain metastases. Autopsy series have confirmed the rarity of brain metastases. When present, brain metastases occur in end stage, once the pca is castrate-resistant and spread t...

  • Case Report
  • Open Access
18 Citations
1,690 Views
4 Pages

Does CDKN2A Loss Predict Palbociclib Benefit?

  • J. Gao,
  • R.P. Adams and
  • S.M. Swain

1 December 2015

Palbociclib, an oral small-molecule inhibitor of cyclin-dependent kinases 4 and 6, was recently approved by the U.S. Food and Drug Administration in combination with letrozole for postmenopausal women with advanced hormone receptor–positive, her2-neg...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729